Management tracks

Spyros Artavanis-Tsakonas is no longer serving as CSO of Biogen Inc. (NASDAQ:BIIB), according to an SEC filing. He is now a visiting scientist, a part-time role. Artavanis-Tsakonas is a professor of cell biology at Harvard Medical School.

Antibody play Prothena Corp. plc (NASDAQ:PRTA) named Sarah Noonberg CMO. She succeeds Martin Koller, who plans to retire at YE17. Noonberg was VP and head of global clinical development at BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)...